Prostate cancer
59 885 new cases in France (latest national estimate, 2018) 1
What is it?
The prostate is a male gland located below the bladder. In about 9 in 10 cases, prostate cancer is an adenocarcinoma, arising from the cells lining the gland 2.
How it develops
Most of these cancers grow slowly; some grow faster. As it progresses, the tumor may extend beyond the prostate capsule, reach the pelvic lymph nodes and then, most often, the bones 2.
How long does it take to develop?
No average development time has been established. One reference point is available: PSA testing can detect this cancer an average of 5 to 8 years before it becomes apparent (about 6,8 years in the European ERSPC trial) 3.
Risk factors
- Age: rare before age 50, with an average age at detection of around 70
- An affected father or brother: more than double the risk
- African or Caribbean ancestry
- Genetic variants (BRCA2, HOXB13, Lynch syndrome), in up to 1 in 10 cases
Signs that should prompt a visit to your doctor
In the early stages
- Most often, no symptoms
As it progresses
- Urinary problems
- Blood in the urine or semen
At an advanced stage
- Back or bone pain
- Fatigue, weight loss
These signs do not mean you have cancer: they may have other causes. Unsure? Talk to your doctor.
⁴Often no signs at first. See a doctor if you have difficulty urinating, blood in your urine or semen, or persistent bone pain. These signs often have a benign cause, such as benign prostate enlargement 5.
Detected early or at a later stage
In France, about 8 in 10 cancers are found at the localized stage, confined to the prostate 1. In the United States: 69 % localized, 14 % regional (lymph nodes), 9 % distant 6.
5-year survival by stage
In France, 5-year net survival: 93 % 7.
Approximate correspondence with the clinical classification (TNM/FIGO); this varies depending on the tumour's characteristics.
Screening in France
No. HAS does not recommend routine PSA screening, because a raised PSA level is often caused by something other than cancer. Individual screening remains an option after discussion with your doctor 8.
Monitoring for people at risk
Practice is moving toward detection tailored to risk level (family history, ancestry), with MRI increasingly performed before any biopsy 9.

Prevonco is currently available in France only.
An aid to the early detection of 16 cancers
No prescription needed, for people without symptoms. If you have an unexplained symptom, see your doctor first.
Pre-register for free →Frequently asked questions
Do I need a prescription?
No. With Prevonco, you do not need a prescription: after ordering online, a unique code gives you access to the test at one of our partner laboratories. In France, some laboratory tests can be carried out at your request, without a prescription.
No prescription, but still a doctor: they remain central to the process. Your result is sent to the doctor you selected from our panel, who will explain it during a 30-minute video consultation, included whatever the result.
Are you receiving care for cancer? Speak directly to your oncologist: they can prescribe this test without going through Prevonco.
For any questions about your situation, or if you have symptoms, your doctor remains your first point of contact.
What if my level is high?
A high level tends to be a strong signal. It is not a conclusion: its cause needs to be investigated with a doctor.¹⁰
Your result is sent to the doctor you selected from our panel. They will explain it during the 30-minute video consultation included in the price. Further investigations prescribed by a doctor can help identify the cause.¹⁰
What if the level is intermediate? It may not be related to cancer (smoking, an inflammatory condition, etc.). Other blood tests may be suggested; if they are normal, a repeat check is planned at 12 months. You will never be left to face your result alone.¹⁰
What if my level is low?
That is reassuring, but no test is perfect: a low level does not rule everything out.¹⁰
If you have no symptoms, no specific follow-up is recommended after a low result. The risk of a false negative varies by cancer type.¹⁰
Your doctor, who is trained in functional medicine and specialises in prevention, will help you explore any concerns or symptoms during the 30-minute video consultation.¹⁰
Keep up with your usual screening: respond to invitations for organised screening programmes, and see your doctor if a symptom appears.¹⁰
How long will it take to get my results?
The laboratory analysis takes 30 days. Your full results are presented by a doctor trained in functional medicine during a 30-minute consultation included in your package.
You choose the date and time slot that suit you for this appointment.
Prevonco is currently available in France only.
An aid to the early detection of 16 cancers
No prescription needed, for people without symptoms. If you have an unexplained symptom, see your doctor first.
Pre-register for free →General information for educational purposes: it does not replace your doctor's advice. An aid to early detection: it does not replace organised screening, imaging tests or your doctor's advice.
Sources
- 1.INCa, Panorama des cancers en France, 2026
- 2.American Cancer Society, What Is Prostate Cancer?
- 3.Finne et al., European Journal of Cancer, 2010 (lead time in the ERSPC trial)
- 4.INCa (cancer.fr, 2016 and 2026); Fondation ARC, 2026
- 5.Santé.fr / INCa, les cancers de la prostate : points clés
- 6.NCI SEER, Cancer Stat Facts – Prostate Cancer (2016-2022)
- 7.Santé publique France, survie des personnes atteintes de cancer 1989-2018
- 8.Assemblée nationale, question écrite n° 8674 sur le dépistage du cancer de la prostate
- 9.American Cancer Society, Prostate Cancer Risk Factors
- 10.biodena.care